Red blood cell ghosts as promising drug carriers to target wound infections

Leaper, 2012, Extending the TIME concept: what have we learned in the past 10 years?(*), Int Wound J, 9, S1, 10.1111/j.1742-481X.2012.01097.x Trivedi, 2014, Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds, J Pathog, 2014, 10.1155/2014/173053 Owens, 2008, Surgical site infections: epidemiology, microbiology and prevention, J Hosp Infect, 70, S3, 10.1016/S0195-6701(08)60017-1 Kinoshita, 2013, Immunoenhancing therapy with interleukin-18 against bacterial infection in immunocompromised hosts after severe surgical stress, J Leukoc Biol, 93, 689, 10.1189/jlb.1012502 Murphy, 2012, Advances in wound healing: a review of current wound healing products, Plast Surg Int, 2012 Church, 2006, Burn wound infections, Clin Microbiol Rev, 19, 403, 10.1128/CMR.19.2.403-434.2006 Fibbe, 1989, The biological activities of interleukin-1, Blut, 59, 147, 10.1007/BF00320059 van der Meer, 1993, Interleukin-1 as a possible agent for treatment of infection, Eur J Clin Microbiol Infect Dis, 12, S73, 10.1007/BF02389883 Kampschmidt, 1985, Rate of clearance of interleukin-1 from the blood of normal and nephrectomized rats, Proc Soc Exp Biol Med, 180, 170, 10.3181/00379727-180-42160 Newton, 1988, The distribution and clearance of radiolabeled human interleukin-1 beta in mice, Lymphokine Res, 7, 207 Vial, 1995, Immune-mediated side-effects of cytokines in humans, Toxicology, 105, 31, 10.1016/0300-483X(95)03124-X Magnani, 2002, Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides, Gene Ther, 9, 749, 10.1038/sj.gt.3301758 Muzykantov, 2010, Drug delivery by red blood cells: vascular carriers designed by mother nature, Expert Opin Drug Deliv, 7, 403, 10.1517/17425241003610633 Antonelli, 2014, Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications, J Biomed Nanotechnol, 10, 1732, 10.1166/jbn.2014.1916 Straat, 2012, Red blood cell clearance in inflammation, Transfus Med Hemother, 39, 353, 10.1159/000342229 Su, 2015, Design strategies and applications of circulating cell-mediated drug delivery systems, ACS Biomater Sci Eng, 1, 201, 10.1021/ab500179h Zhumadilov, 1990, Specificity of loading some antibiotics into erythrocytes shadows as a system for targeted delivery of the chemotherapeutics, Antibiot Chemother, 54 Millán, 2008, Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes, J Antimicrob Chemother, 61, 375, 10.1093/jac/dkm477 Magnani, 2012, Erythrocytes as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics, Ther Deliv, 3, 405, 10.4155/tde.12.6 Tajerzadeh, 2000, Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes, Drug Dev Ind Pharm, 26, 1247, 10.1081/DDC-100102306 Turebaev, 2010 Rescigno, 2004, On the use of pharmacokinetic models, Phys Med Biol, 49, 4657, 10.1088/0031-9155/49/19/014 Lizano, 2001, Mouse erythrocytes as carriers for coencapsulated alcohol and aldehyde dehydrogenase obtained by electroporation in vivo survival rate in circulation, organ distribution and ethanol degradation, Life Sci, 68, 2001, 10.1016/S0024-3205(01)00991-2 Haroon, 2000, Early wound healing exhibits cytokine surge without evidence of hypoxia, Ann Surg, 231, 137, 10.1097/00000658-200001000-00020 Burnouf, 2013, Blood-derived biomaterials and platelet growth factors in regenerative medicine, Blood Rev, 27, 77, 10.1016/j.blre.2013.02.001 Klapproth, 1989, Fate and biological action of human recombinant interleukin 1 beta in the rat in vivo, Eur J Immunol, 19, 1485, 10.1002/eji.1830190821 Kudo, 1990, Clearance and tissue distribution of recombinant human interleukin 1 beta in rats, Cancer Res, 50, 5751 Djaldetti, 2002, Phagocytosis–the mighty weapon of the silent warriors, Microsc Res Tech, 57, 421, 10.1002/jemt.10096 Yamashita, 2013, Pharmacokinetic considerations for targeted drug delivery, Adv Drug Deliv Rev, 65, 139, 10.1016/j.addr.2012.11.006